KI-Beratung Beta

Produktbild: To Formulate and Evaluate Sustained Release Matrix Tablets of Mosaprid
- 13%

To Formulate and Evaluate Sustained Release Matrix Tablets of Mosaprid (For Gastro-Esophageal Reflux Disease)

13% sparen

37,99 € UVP 43,90 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

The present study was carried out to develop sustained release matrix tablets of mosapride citrate dihydrate. Matrix tablets of mosapride citrate dihydrate with two different viscosity grades of hydroxypropyl methylcellulose were prepared by dry granulation and direct compression method and evaluated.The...

Beschreibung

The present study was carried out to develop sustained release matrix tablets of mosapride citrate dihydrate. Matrix tablets of mosapride citrate dihydrate with two different viscosity grades of hydroxypropyl methylcellulose were prepared by dry granulation and direct compression method and evaluated.The study demonstrated that combination of HPMC K4M and HPMC mosapride citrate dihydrate. This can be expected to reduce the frequency of administration and decrease the dose - dependent side effects associated with repeated administration of conventional mosapride citrate dihydrate tablets. The cumulative drug release of innovators brand (MOZA SR, Intas Pharmaceuticals) of sustained release tablet of mosapride citrate dihydrate were compaired for in vitro dissolution study.Hence it can be concluded that once daily sustain release matrix tablet of mosapride citrate dihydrate having short half life, was found to exert a satisfactory sustained release profile which may provide an improved bioavailability, increased therapeutic efficacy and patient compliance.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

20.06.2022

Verlag LAP LAMBERT Academic Publishing
Seitenzahl

88

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

20.06.2022

Verlag LAP LAMBERT Academic Publishing
Seitenzahl

88

Maße (L/B/H)

22/15/0,6 cm

Gewicht

149 g

Sprache

Englisch

ISBN

978-620-4-97780-5

Herstelleradresse


Email: info@bod.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: To Formulate and Evaluate Sustained Release Matrix Tablets of Mosaprid